Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Multi-centre, randomized, investigator-blind, intra-individual active and vehicle-controlled study, comparing Metvix Natural Daylight Photodynamic Therapy versus Metvix conventional Photodynamic Therapy in subjects with actinic keratosis [Estudio multicentrico, aleatorizado, enmascarado para el investigador, con control intraindividual con fármaco activo y con vehículo, de comparación entre el tratamiento fotodinámico Metvix con luz solar natural y el tratamiento fotodinamico Metvix convencional en pacientes con queratosis actínica]

Next Previous
X
Search
Trial Profile

Multi-centre, randomized, investigator-blind, intra-individual active and vehicle-controlled study, comparing Metvix Natural Daylight Photodynamic Therapy versus Metvix conventional Photodynamic Therapy in subjects with actinic keratosis [Estudio multicentrico, aleatorizado, enmascarado para el investigador, con control intraindividual con fármaco activo y con vehículo, de comparación entre el tratamiento fotodinámico Metvix con luz solar natural y el tratamiento fotodinamico Metvix convencional en pacientes con queratosis actínica]

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 09 Feb 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Methyl aminolevulinate (Primary)
  • Indications Actinic keratosis
  • Focus Registrational; Therapeutic Use
  • Acronyms COMET2
  • Sponsors Galderma

    • Most Recent Events

    • 11 Sep 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 26 Jul 2013 Planned end date changed from 1 Feb 2014 to 1 Mar 2014 as reported by ClinicalTrials.gov.
    • 15 Jun 2013 New source identified and integrated (European Clinical Trials Database, EudraCT2013-000973-54).

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top